Abstract
Objective: Herpes simplex virus encephalitis (HSVE) is associated with significant morbidity and mortality, even with appropriate antiviral therapy. In the present investigation, the first to assess efficacy of corticosteroid treatment with aciclovir therapy in HSVE, multiple logistic regression analysis was performed of predictors of outcome in adult patients with HSVE.
Methods: A non-randomised retrospective study of 45 patients with HSVE treated with aciclovir was conducted. The patients were divided into poor and good groups based on outcome at three months after completion of aciclovir treatment. The variables evaluated were: clinical variables (sex, age, days after onset at initiation of aciclovir, Glasgow Coma Scale (GCS) at initiation of aciclovir, initial and maximum values for the cell numbers and protein concentration in the cerebrospinal fluid, and corticosteroid administration); neuroradiological variables (detection of lesions by initial cranial computed tomography and by initial magnetic resonance imaging); and one neurophysiological variable (detection of periodic lateralised epileptiform discharges on the initial electroencephalogram). Single variable logistic regression analysis was performed followed by multiple logistic regression analysis. The best set of predictors for the outcome of HSVE was estimated by stepwise logistic regression analysis.
Results: A poor outcome was evident with older age, lower GCS score at initiation of aciclovir, and no administration of corticosteroid. Patient age, GCS at initiation of aciclovir, and corticosteroid administration were found to be significant independent predictors of outcome on multiple logistic regression analysis, and these three variables also formed the best set of predictors (R2 = 0.594, p<0.0001).
Conclusion: Combination therapy using both aciclovir and corticosteroid represents one of the predictors of outcome in HSVE.
Full Text
The Full Text of this article is available as a PDF (72.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kamei S., Takasu T., Morishima T., Yoshihara T., Tetsuka T. Comparative study between chemiluminescence assay and two different sensitive polymerase chain reactions on the diagnosis of serial herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):596–601. doi: 10.1136/jnnp.67.5.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marton R., Gotlieb-Steimatsky T., Klein C., Arlazoroff A. Acute herpes simplex encephalitis: clinical assessment and prognostic data. Acta Neurol Scand. 1996 Feb-Mar;93(2-3):149–155. doi: 10.1111/j.1600-0404.1996.tb00191.x. [DOI] [PubMed] [Google Scholar]
- Meyding-Lamadé Uta K., Oberlinner Christoph, Rau Philipp R., Seyfer Sonja, Heiland Sabine, Sellner Johann, Wildemann Brigitte T., Lamadé Wolfram R. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol. 2003 Feb;9(1):118–125. doi: 10.1080/13550280390173373. [DOI] [PubMed] [Google Scholar]
- Misra U. K., Kalita J., Roy A. K., Mandal S. K., Srivastava M. Role of clinical, radiological, and neurophysiological changes in predicting the outcome of tuberculous meningitis: a multivariable analysis. J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):300–303. doi: 10.1136/jnnp.68.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morawetz R. B., Whitley R. J., Murphy D. M. Experience with brain biopsy for suspected herpes encephalitis: a review of forty consecutive cases. Neurosurgery. 1983 Jun;12(6):654–657. doi: 10.1227/00006123-198306000-00011. [DOI] [PubMed] [Google Scholar]
- Oshima M., Azuma H., Suzutani T., Ikeda H., Okuno A. Direct and mononuclear cell mediated effects on interleukin 6 production by glioma cells in infection with herpes simplex virus type 1. J Med Virol. 2001 Mar;63(3):252–258. doi: 10.1002/1096-9071(200103)63:3<252::aid-jmv1009>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Raschilas Franck, Wolff Michel, Delatour Frédérique, Chaffaut Cendrine, De Broucker Thomas, Chevret Sylvie, Lebon Pierre, Canton Philippe, Rozenberg Flore. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis. 2002 Jul 10;35(3):254–260. doi: 10.1086/341405. [DOI] [PubMed] [Google Scholar]
- Sköldenberg B., Forsgren M., Alestig K., Bergström T., Burman L., Dahlqvist E., Forkman A., Frydén A., Lövgren K., Norlin K. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984 Sep 29;2(8405):707–711. doi: 10.1016/s0140-6736(84)92623-0. [DOI] [PubMed] [Google Scholar]
- Thompson K. A., Blessing W. W., Wesselingh S. L. Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes encephalitis. J Neurovirol. 2000 Feb;6(1):25–32. doi: 10.3109/13550280009006379. [DOI] [PubMed] [Google Scholar]
- Whitley R. J., Alford C. A., Hirsch M. S., Schooley R. T., Luby J. P., Aoki F. Y., Hanley D., Nahmias A. J., Soong S. J. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16;314(3):144–149. doi: 10.1056/NEJM198601163140303. [DOI] [PubMed] [Google Scholar]
- Whitley R. J., Cobbs C. G., Alford C. A., Jr, Soong S. J., Hirsch M. S., Connor J. D., Corey L., Hanley D. F., Levin M., Powell D. A. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA. 1989 Jul 14;262(2):234–239. [PubMed] [Google Scholar]
- Whitley R. J., Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis. 1995 Feb;20(2):414–420. doi: 10.1093/clinids/20.2.414. [DOI] [PubMed] [Google Scholar]